Weather forecast

Eli Lilly (LLY) stock forecast

Sunny

Buy

Score 70/100 · Confidence 78%

The outlook is bright — conditions favour stepping in.

Weighed fromlive price action

Why this call

Riding a Wave of Blockbuster Drugs

Exceptional revenue growth near 50%

Strong investor sentiment following positive drug data

Sustained price momentum over the past year

Under the hood

What the engine weighed

Six factors, scored 0–100 from live market and financial data — the same read Wall Street does, minus the jargon.

70Overall score
Valuation
25

The stock's valuation is high, reflecting lofty market expectations.

Growth
95

Revenue growth is exceptional, among the best for a company of this size.

Profitability
90

The company operates with excellent, best-in-class profit margins.

Momentum
92

The stock is in a very strong and sustained uptrend at all timeframes.

Fin. health
55

The company's balance sheet carries a notable amount of debt.

Sentiment
75

Recent news flow has been constructive, focusing on positive clinical data.

The argument

Both sides of the sky

Every call has a case against it. Here's the honest version of both.

The bull case

  • Explosive revenue growth of nearly 50% year-over-year, driven by its wildly successful drug pipeline.
  • Exceptional profitability, with a net margin over 33%, turning a large portion of sales into profit.
  • Strong positive momentum, with the stock price consistently hitting new highs and supported by positive clinical trial news.

The bear case

  • The stock trades at a high valuation (P/E of 43.8), meaning very high expectations are already priced in.
  • The company carries a notable amount of debt, with a Debt-to-Equity ratio of 1.62.
  • Heavy reliance on a few key drugs creates risk if competitors emerge or regulatory landscapes change.
Sunny, Tickerday's mascot, fast asleep under the stars

Get the full picture

That took thirty seconds. Now imagine every stock you own.

You just understood LLY without reading a single chart. The Tickerday app does this for your whole watchlist — the full thesis, price targets from next week to next year, bull and bear scenarios — and wakes you the moment the weather turns.

One plain answer for every stock — Buy, Hold, or Sell

The full picture in seconds — thesis, targets & scenarios

Sleep easy — we watch the market and wake you if it turns

Free to download the day it lands — the web desk is open now

More forecasts